Key Findings:  Results of this trial suggest that CBD-enriched cannabis extract may ameliorate multiple ASD-related symptoms with a significant increase in quality of life for both ASD patients and their caretakers.
Type of Study:  Clinical Trial
Study Sample Size:  18
Study Result:  Positive
Study Location(s):  Brazil
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Cannabis Flower derived
Chemotype:  Chemotype III
Sub-Ratio: 1:75 (THC:CBD)
Dosage: CBD (25 or 50 mg) and THC (~0.34 or 0.68 mg)
Route of Administration:  Oral (Ingestion)